The Role of Artificial Intelligence in Oral Cancer: A Review of Current Applications and Future Directions
Main Article Content
Abstract
Oral cancer remains a major global health concern with high morbidity and mortality, largely due to delays in detection and challenges in accurate diagnosis. Traditional methods such as visual examination, biopsy, and histopathological review can be time-consuming, subjective, and limited by clinician experience. In recent years, artificial intelligence has shown promise in improving the accuracy and efficiency of oral cancer care. Deep learning models support early detection by identifying suspicious lesions on clinical photographs and histopathology images, while digital pathology systems help reduce inter-observer variability. AI-based tools are also contributing to risk assessment, prognosis prediction, and treatment planning, including radiotherapy dose optimization and surgical margin evaluation. Mobile health applications and wearable devices enhance patient monitoring and support long-term follow-up by identifying changes that may indicate recurrence. Despite these advances, concerns related to data quality, model transparency, privacy, and regulatory approval remain barriers to widespread adoption. Looking ahead, integrating imaging, clinical data, and molecular information may enable more personalized treatment strategies. With careful clinical validation and responsible implementation, AI has the potential to complement clinician judgment and improve outcomes across the oral cancer care continuum.
Article Details

This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Sung H, Ferlay J, Siegel RL, et al. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71(3):209-249. doi:10.3322/caac.21660.
II. Rivera C. (2022). Essentials of oral cancer. International Journal of Clinical and Experimental Pathology, 15(5):187-196.
III. Bianchi A, Amadori F, Calvani F, et al. (2024). Artificial intelligence in oral cancer: a systematic review of current applications and performance. BMC Oral Health, 24:3993. doi:10.1186/s12903-024-03993-5.
IV. Awan MJ, Alqahtani A, Khan SA, et al. (2022). Deep learning for early detection and classification of oral squamous cell carcinoma: a multi-institutional study. Frontiers in Oncology, 12:893167. doi:10.3389/fonc.2022.893167.
V. Wang J, Qiu J, Zhang Y, et al. (2023). Deep learning–assisted pathology in oral squamous cell carcinoma improves diagnostic accuracy and efficiency. Journal of Pathology Informatics, 14:100152.doi:10.1016/j.jpi.2023.100152.
VI. Topol EJ. (2019). High-performance medicine: the convergence of human and artificial intelligence. Nat Med. 25(1):44-56.
doi:10.1038/s41591-018-0300-7.
VII. Esteva A, et al. (2021). Deep learning-enabled medical computer vision. NPJ Digit Med. 4(1):5. doi:10.1038/s41746-020-00376-2.
VIII. Yu KH, et al. (2022). Artificial intelligence in clinical oncology: current developments and future directions. Nat Rev Clin Oncol. 19(12):735-750. doi:10.1038/s41571-022-00731-5.
IX. Liu X, et al. (2022). Natural language processing in oncology: a review. JAMA Oncol. 8(10):1472-1479. doi:10.1001/jamaoncol.2022.2399.
X. 6. Sastry A, et al. (2020). Artificial intelligence in oral cancer: Computer vision, clinical applications, and future directions. Oral Oncol. 110:104885. doi:10.1016/j.oraloncology.2020.104885.
XI. 7. Yang L, et al. (2022). Deep learning for early detection and classification of oral squamous cell carcinoma on histopathological images. Oral Oncol. 128:105812. doi:10.1016/j.oraloncology.2022.105812.
XII. 8. Lu C, et al. (2021). Deep learning for identifying malignant transformation in oral potentially malignant disorders. J Pathol Inform. 12:26. doi:10.4103/jpi.jpi_69_20.
XIII. Fu Q, et al. (2020). A deep learning algorithm for detection of oral cancer using images from an intraoral camera. Oral Oncol. 108:104920. doi:10.1016/j.oraloncology.2020.104920. PubMed
XIV. Zhang L, Zhang X, Fan Z, et al. (2021). Machine learning-based risk stratification for oral squamous cell carcinoma using clinical and demographic variables. BMC Cancer. 21:980.
doi:10.1186/s12885-021-08714-1.
XV. Zhu X, Chen L, Jin L, et al. (2022). Deep learning radiomics for prediction of lymph node metastasis and recurrence in oral squamous cell carcinoma. Oral Oncol. 134:106075.
doi:10.1016/j.oraloncology.2022.106075.
XVI. Qin Y, Li Z, Wang Y, et al. (2021). Histopathology-based deep learning model predicts lymph node metastasis in oral cancer. Mod Pathol. 34(6):1049-1057. doi:10.1038/s41379-020-00714-7.
XVII. Lai C, Wang J, Wu H, et al. (2023). MRI-based radiomics and machine learning for survival prediction in oral cavity cancer. Front Oncol. 13:1123489. doi:10.3389/fonc.2023.1123489.
XVIII. Lin CS, Lin YJ, Wang WC, et al. (2021). Machine learning-assisted multi-omics analysis for molecular risk prediction in oral squamous cell carcinoma. Cancers (Basel). 13(12):3071.
doi:10.3390/cancers13123071.
XIX. Song D, Shen S, Wu Y, et al. (2023). Integrated multi-omics model improves prediction of recurrence-free survival in oral cancer patients. Front Genet. 14:1121348.
doi:10.3389/fgene.2023.1121348.
XX. Wang W, Gao S, Zhao C, et al. (2022). Biomarker-driven machine learning model for predicting malignant transformation of oral potentially malignant disorders. Front Oncol. 12:895956.
doi:10.3389/fonc.2022.895956.
XXI. 17.Peltonen H, Koivunen P, Veira K, et al. Current role of artificial intelligence in head and neck cancer surgery: a systematic review. Eur Arch Otorhinolaryngol. 2024;281(1):17–26. doi:10.1007/s00405-023-07621-3. PMID:
XXII. Robotti M, Dell’Oglio P, Vanoni V, et al. Artificial intelligence-supported applications in head and neck cancer radiotherapy treatment planning and dose optimisation. Radiat Oncol. 2023;18(1):120. doi:10.1186/s13014-023-02155-3. PMID:
XXIII. Van Dyk J, Abdel-Wahab M, Zubizarreta E, et al. Evaluation of deep learning to augment image-guided radiotherapy for head and neck and prostate cancers. JAMA Netw Open. 2022;5(11):e2242684. doi:10.1001/jamanetworkopen.2022.42684.
XXIV. Mukul SK, Rashid S, Gupta VA, Kalimuddin KS. Artificial intelligence for real-time resection margin evaluation in oral cancer: a future perspective. J Orofac Res. 2025;14(1):1–4.
XXV. Kandasamy R, Malhotra S, Akram H, et al. The integration of artificial intelligence into robotic cancer surgery. Preprint. 2025;Version 1:1–16. doi:10.20944/preprints202503.0087.v1.
XXVI. Kim J, et al. Mobile health application-based oral cancer surveillance and patient engagement. J Oral
Maxillofac Surg. 2021;79(6):1295-1303. PMID: 33550098.
XXVII. Gupta V, et al. Wearable sensor-based monitoring for functional outcomes after head and neck cancer treatment. Head Neck. 2022;44(8):1866-1875.
PMID: 35510932.
XXVIII. Kong F, et al. Deep learning–based recurrence prediction using longitudinal clinical data in head and neck cancer. Cancers (Basel).
;12(11):3357. PMID: 33213018.
XXIX. Wen N, et al. Multimodal deep learning for recurrence prediction in head and neck cancer using longitudinal imaging and clinical data. Radiother Oncol. 2023;183:109592. PMID: 37089503.
XXX. Abdelrahman SM, Li K, Jahanbakhshi A, et al. Challenges in digital pathology and artificial intelligence in head and neck cancers. Cancers (Basel). 2023;15(3):789.
doi:10.3390/cancers15030789. PMID: 36768942.
XXXI. Rajpurkar P, Chen E, Banerjee O, Topol EJ. AI in health and medicine. Nat Med. 2022;28(1):31–38. doi:10.1038/s41591-021-01614-0.
PMID: 35714556.
XXXII. Huang S, Yang J, Fong S, Zhao Q. Artificial intelligence in cancer pathology: a multi-modal deep learning approach. Comput Struct Biotechnol J. 2020;18:4889–4898. doi:10.1016/j.csbj.2020.09.032. PMID: 33062543.
XXXIII. Liu Y, Wu L, Zhang Q, et al. Personalized oncology powered by machine learning and multi-omics data integration. Brief Bioinform. 2023;24(2):bbad025. doi:10.1093/bib/bbad025. PMID: 36757603.
XXXIV. Rieke N, Hancox J, Li W, et al. The future of medical imaging: federated learning. NPJ Digit Med. 2020;3:119. doi:10.1038/s41746-020-00323-1. PMID: 33117937.
XXXV. Li L, Pu C, Tao J, Zhu L, Hu S, Qiao B, Xing L, Wei B, Shi C, Chen P, Zhang H. Development of an oral cancerdetection system through deep learning. BMC Oral Health. 2024 Dec 4;24(1):1468. doi: 10.1186/s12903-024-05195-5.
XXXVI. Kim DW, Lee S, Kwon S, Nam W, Cha IH, Kim HJ. Deep learning-based survival prediction of oral cancerpatients. Sci Rep. 2019 May 6;9(1):6994. doi: 10.1038/s41598-019-43372-7.
XXXVII. Albalawi E, Thakur A, Ramakrishna MT, Bhatia Khan S, SankaraNarayanan S, Almarri B, Hadi TH. Oralsquamous cell carcinoma detection using EfficientNet on histopathological images. Front Med(Lausanne). 2024 Jan 29;10:1349336.
doi: 10.3389/fmed.2023.1349336.
XXXVIII. Yuan W, Rao J, Liu Y, Li S, Qin L, Huang X. Deep radiomics-based prognostic prediction of oral cancerusing optical coherence tomography. BMC Oral Health. 2024 Sep 19;24(1):1117.
doi: 10.1186/s12903-024-04849-8.
XXXIX. Sunny S, Baby A, James BL, Balaji D, N V A, Rana MH, Gurpur P, Skandarajah A, D’Ambrosio M,Ramanjinappa RD, Mohan SP, Raghavan N, Kandasarma U, N S, Raghavan S, Hedne N, Koch F, FletcherDA, Selvam S, Kollegal M, N PB, Ladic L, Suresh A, Pandya HJ, Kuriakose MA. A smart tele-cytology point-of-care platform for oral cancer screening. PLoS One. 2019 Nov
;14(11):e0224885. doi:10.1371/journal.pone.0224885.
XL. Veeraraghavan VP, Daniel S, Dasari AK, Aileni KR, Patil SR. Harnessing artificial intelligence for predictivemodelling in oral oncology: Opportunities, challenges, and clinical Perspectives. Oral Oncology Reports.2024 Sep 1;11:100591.
XLI. Schmidl B, Hütten T, Pigorsch S, Stögbauer F, Hoch CC, Hussain T, Wollenberg B, Wirth M. Artificialintelligence for image recognition in diagnosing oral and oropharyngeal cancer and leukoplakia. Sci Rep.2025 Jan 29;15(1):3625.
doi: 10.1038/s41598-025-85920-4.
XLII. Schomberg J. Identification of Targetable Pathways in Oral Cancer Patients via Random Forest andChemical Informatics. Cancer Inform. 2019 Nov 28;18:1176935119889911. doi:10.1177/1176935119889911.